About RoslinCT

We translate and develop your cell and gene therapy research into robust cGMP qualified processes through our experience and expertise.
RoslinCT is a leading Cell Therapy Contract Development and Manufacturing Organisation (CDMO) enabling you to bring your autologous or allogeneic therapy safely to the patient.
cell therapy
scientist, RoslinCT, cell therapies
clean room, science, cell and gene therapies, GMP

Our Services

Bringing your cell therapy products to the market

RoslinCT offers a range of integrated services from GMP translation of research protocols, analytical assay development and process development through to GMP manufacturing and QP batch release of cell-based therapies for clinical trials and commercialisation.


Cell and gene therapy insight from our experts and industry leaders


    Working with us
    • “We have been very impressed by the professional and flexible approach of RoslinCT throughout our collaborations and highly recommend them as a trusted partner for the development of advanced therapies.”

      David Bunton, CEO, REPROCELL Europe
    • “We love working with the team at RoslinCT. It is a team that has strong values and an obvious strive for excellence in everything they do. We particularly admire the commitment the leaders of the business show to their people: they hire carefully, invest in development and look for ways to provide staff with fresh opportunity wherever they can.”

      Lis McCormick, Director, McCormick Consultants
    • “RoslinCT are an integral part of the advanced therapies infrastructure in the UK as a long-established CDMO. Their depth of experience and capabilities allows them to provide high-quality end-to-end support to their clients. RoslinCT are also leading the National Training Centre for the ATSTN aiming to provide specialist training and industry growth.”

      Lee Dunham, Senior Collaborations Strategy Manager,Cell and Gene Therapy Catapult